This open label 4 month study will evaluate efficacy (blood pressure lowering effects) and safety of lisinopril in children 1-18y whose parents grant permission to participate. This dose titration study is being conducted to support the statement that personalized titration of lisinopril (based on blood pressure and renin-aldosterone ratio) can increase patient response.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
13
Lisinopril 0.1mg/kg/d, titration with + 0.1mg/kg/d. Max; daily dose: 0.4mg/kg. CAVE: dose reduction in case of renal impairment
Department of Pediatrics and Medical Genetics
Ghent, Belgium
blood pressure
Time frame: 4 months
Serum concentrations will be assessed after every dose titration
Time frame: trough and 4 hours post dosing
Adverse events with assessment of specific blood parameters
sodium, potassium, creatinine, bilirubin, aspartate transaminase/alanine transaminase (AST/ALT) and blood count
Time frame: up to 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.